Show simple item record

dc.contributor.authorScholz, Sean S.
dc.contributor.authorLauder, Lucas
dc.contributor.authorEwen, Sebastian
dc.contributor.authorKulenthiran, Saarraaken
dc.contributor.authorMarx, Nikolaus
dc.contributor.authorSakhov, Orazbek
dc.contributor.authorKauer, Floris
dc.contributor.authorWitkowski, Adam
dc.contributor.authorVaglimigli, Marco
dc.contributor.authorWijns, William
dc.contributor.authorScheller, Bruno
dc.contributor.authorBöhm, Michael
dc.contributor.authorMahfoud, Felix
dc.date.accessioned2020-08-31T23:51:44Z
dc.date.available2020-08-31T23:51:44Z
dc.date.issued2019-12
dc.date.submitted2019-09
dc.identifier.issn1861-0684
dc.identifier.issn1861-0692
dc.identifier.urihttps://hdl.handle.net/1721.1/126861
dc.description.abstractAbstract Background Chronic kidney disease (CKD) is highly prevalent in patients with coronary artery disease (CAD). Objective The outcome following revascularization using contemporary technologies (new-generation abluminal sirolimus-eluting stents with thin struts) in patients with CKD (i.e., glomerular filtration rate of < 60 mL/min/1.73m2) and in patients with hemodialysis (HD) is unknown. Methods e-Ultimaster is a prospective, single-arm, multi-center registry with clinical follow-up at 3 months and 1 year. Results A total of 19,475 patients were enrolled, including 1466 patients with CKD, with 167 undergoing HD. Patients with CKD had a higher prevalence of overall comorbidities, multiple/small vessel disease (≤ 2.75 mm), bifurcation lesions, and more often left main artery treatments (all p < 0.0001) when compared with patients with normal renal function (reference). CKD patients had a higher risk of target lesion failure (unadjusted OR, 2.51 [95% CI 2.04–3.08]), target vessel failure (OR, 2.44 [95% CI 2.01–2.96]), patient-oriented composite end point (OR, 2.19 [95% CI 1.87–2.56]), and major adverse cardiovascular events (OR, 2.34 [95% CI 1.93–2.83, p for all < 0.0001]) as reference. The rates of target lesion revascularization (OR, 1.17 [95% CI 0.79–1.73], p = 0.44) were not different. Bleeding complications were more frequently observed in CKD than in the reference (all p < 0.0001). Conclusion In this worldwide registry, CKD patients presented with more comorbidities and more complex lesions when compared with the reference population. They experienced higher rate of adverse events at 1-year follow-up. Graphic abstract One-year summary outcomes of contemporary PCI in renal insufficiency. CKD chronic kidney disease, POCE patient oriented composite endpoint, MACE major adverse cardiovascular events, TLF target lesion failure, TLR target lesion revascularization, ST stent thrombosisen_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttp://dx.doi.org/10.1007/s00392-019-01575-yen_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceSpringer Berlin Heidelbergen_US
dc.titleOne-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registryen_US
dc.typeArticleen_US
dc.identifier.citationScholz, Sean S. et al. "One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry." Clinical Research in Cardiology 109, 7 (December 2019): 845–856 © 2019 Springer Natureen_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.relation.journalClinical Research in Cardiologyen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-06-26T12:34:34Z
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dspace.embargo.termsN
dspace.date.submission2020-06-26T12:34:34Z
mit.journal.volume109en_US
mit.journal.issue7en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record